企业基因视角下医药企业竞争力测度  

The Measurement of Competitiveness of Pharmaceutical Enterprises from the Perspective of Enterprise Genes

作　　者：李伟明 秦莹 江涛涛 毛良虎 Li Weiming;Qin Ying;Jiang Taotao;Mao Lianghu

机构地区：[1]常州大学怀德学院 [2]常州大学商学院

出　　处：《常州大学学报（社会科学版）》2023年第1期62-67,共6页Journal of Changzhou University:Social Science Edition

基　　金：国家社会科学基金一般项目“基于知识产权资本测度的企业家精神度量研究”(17BTJ012);江苏省哲学社会科学基金一般项目“基于企业基因的江苏建设世界一流企业的成长测度”(21GLB002)。

摘　　要：基于双链四碱基仿生模型,构建了包含4个一级指标和15个二级指标的医药企业竞争力综合测量指标体系,并运用熵权TOPSIS法对中国30家医药企业进行综合测度,得出以下结论:第一,通过文献研究构建了医药企业竞争力双链四碱基模型,其中,双链包括知识链和资本链,四碱基包括企业家、财务、技术、经营能力。第二,医药企业竞争力四个碱基的重要程度依次为技术、财务、经营能力、企业家。第三,对我国30家上市医药企业竞争力进行了测度,并根据测度结果将医药企业基因划分为一路领先型、冲刺型、平稳型、追赶型、退步型等5种类型。Based on the bionic model of double strands and four bases,a comprehensive measurement index system of pharmaceutical enterprise competitiveness is constructed containing four first-level indexes and fifteen second-level indexes,and 30 Chinese pharmaceutical enterprises are comprehensively measured by the use of entropy weight TOPSIS method.It is concluded that firstly,through literature review,the model of double strands and four bases of pharmaceutical enterprise competitiveness is constructed,among them double strands are knowledge strand and capital strand,and four bases are entrepreneur,finance,technology and management ability.Secondly,the order of importance of the four bases of pharmaceutical enterprise competitiveness is respectively technology,finance,management ability and entrepreneur.Thirdly,the competitiveness of 30 listed Chinese pharmaceutical enterprises is measured,and based on the results,pharmaceutical enterprise genes are classified into five types of lead type,sprint type,stable type,catch-up type and retrogressive type.

关 键 词：企业基因 医药企业 企业竞争力 

分 类 号：F272[经济管理—企业管理]